NLRC5 and breast carcinoma: Treatment with plasma isolated from BALB/c mice after injection with IFN-γ for 24-h, the relative levels of NLRC5 in SKBR3 breast cancer cells were increased, compared with the control group (treatment with plasma isolated from BALB/c mice after injection with PBS) with statistical significance (p < .05) (Figure 2b).